This $1 Stock is a ‘Strong Buy’ with 213% Upside Potential
Increased holdings by hedge funds, a research collaboration, and a clinical hold lifted by the FDA are catalysts that could send shares higher.
Written byTrades Of The Day Research TeamSource: Trades Of The Day
Increased holdings by hedge funds, a research collaboration, and a clinical hold lifted by the FDA are catalysts that could send shares higher.